Syschem (India) Ltd.

57.00 -0.17 ▼-0.3%

04 March 2024, 04:01:00 PM
Volume: 21,124

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syschem.in
Market Cap 227.22 Cr.
Enterprise Value(EV) 228.40 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.86 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 66.57 Trailing Twelve Months Ending 2023-12
Industry PE 41.59 Trailing Twelve Months Ending 2023-12
Book Value / Share 14.35 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.97 Calculated using Price: 57.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.99 Cr. 39,863,000 Shares
FaceValue 10
About Syschem (India) Ltd.
Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.

Syschem (India) Ltd. Delivery

Delivered Qty
Traded Qty

Syschem (India) Ltd. Performance

1 Day
-0.30%
1 Week
-1.74%
1 Month
-9.97%
3 Month
+11.76%
6 Month
+18.75%
1 Year
+30.94%
2 Year
+361.54%
5 Year
+571.38%
10 Year
+696.09%

Syschem (India) Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -32.44 -25.21 -19.78 4.43 7.67 -17.24 -66.17 -26.16 31.84
Return on Capital Employed (%) -10.6 -8.3 -6.68 2.68 5.51 -8.22 -29.75 -12.18 38
Return on Assets (%) -7.41 -4.69 -3.41 0.69 1.3 -3.06 -8.28 -2.64 6.17

Syschem (India) Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 11 9 7 9 12 10 7 7 22 25
Non Curr. Liab. 20 19 13 12 11 12 26 23 25 30
Curr. Liab. 19 18 22 34 37 39 41 26 43 29
Minority Int.
Equity & Liab. 50 45 42 56 61 61 74 56 90 84
Non Curr. Assets 35 33 31 30 28 30 32 32 32 34
Curr. Assets 15 13 11 26 32 31 42 24 59 50
Misc. Exp. not W/O
Total Assets 50 45 42 56 61 61 74 56 90 84

Syschem (India) Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 11 4 13 67 93 77 68 59 114 202
Other Income 0 0 0 0 0 0 0 0
Total Income 11 4 13 67 93 77 69 59 114 202
Total Expenditure -14 -5 -13 -63 -90 -77 -74 -58 -105 -195
PBIDT -3 -1 0 3 4 0 -5 1 9 8
Interest -1 0 0 0 0 0 0 0 0 0
Depreciation -2 -2 -2 -2 -2 -2 -2 -3 -3 -3
Taxation 1 1 1 0 -1 0 2 0 -2 -2
Exceptional Items 0
PAT -4 -2 -1 0 1 -2 -6 -2 5 3
Adjusted EPS -2 -1 -1 0 0 -1 -2 -1 1 1

Syschem (India) Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 1 0 6 0 -2 3 4 1 -8
Cash Fr. Inv. -3 0 0 0 0 2 -4 -4 -1 9
Cash Fr. Finan. -1 -2 -1 -7 0 0 0 0 0 0
Net Change 0 -1 0 0 0 0 0 0 1
Cash & Cash Eqvt 1 0 0 0 0 0 0 0 0 1

Syschem (India) Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 16.34 16.34 21.78 52.10 53.82 53.82 53.82 53.79 53.89
Public 83.66 83.66 78.22 47.90 46.18 46.18 46.18 46.21 46.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Syschem (India) Ltd. Announcements

Mon, 26 Feb 2024
Announcement Under Regulation 30: Update On The Petition
Announcement under regulation 30: Update on Petition received by Company filled under NCLT Chandigarh bench.
Sat, 10 Feb 2024
Intimation Under Regulation 47(3) Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Intimation under regulation 47(3) (Listing Obligations and Disclosure Requirements) 2015 : Advertisements of Results approved in the Board Meeting dated 09-02-2024 for the quarter ended 31-12-2023.
Fri, 09 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Dated 09-02-2024 For The Quarterly Results 31-12-2023
Outcome of Board Meeting for the quarterly results 31-12-2023

Syschem (India) Ltd. Technical Scans

Mon, 04 Mar 2024
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
Doji and Near Doji Doji and Near Doji

Syschem (India) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 372,436.77 1,552.25 +0.1%
Cipla Ltd. 118,783.64 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. 105,691.98 6,335.95 +1.5%
Zydus Lifesciences Ltd. 95,764.63 946.10 +2.5%
Divi's Laboratories Ltd. 92,421.56 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. 91,038.44 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. 86,787.70 6,049.65 -1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.82 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-12 32.03 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.22 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.20 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-12 66.83 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.94 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 109.95 6,049.65 -1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.97 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-12 4.59 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.93 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.93 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.09 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.85 6,049.65 -1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,049.65 -1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,049.65 -1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,049.65 -1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,049.65 -1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,552.25 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,471.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,335.95 +1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 946.10 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,481.45 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,689.10 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,049.65 -1.4%

Syschem (India) Ltd. FAQ's

What is Syschem (India) share price?

Can I buy Syschem (India) shares now?

What is the Market Cap of Syschem (India)?

What are the key metrics to analyse Syschem (India)?

What is the 52 Week High and Low of Syschem (India)?

What is the trend of Syschem (India) share price?